Abstract
The mechanism of increased serum creatinine after administration of pyrimethamine and dapsone was evaluated for six healthy volunteers. Serum parameters, urine sediment, and clearances of creatinine, inulin, and para-aminohippurate were assessed prior to and 28 h after the ingestion of a single, combined dose of 100 mg of pyrimethamine and 200 mg of dapsone. In a second series, the same renal function tests were performed for nine human immunodeficiency virus-infected men before and after 1 month of prophylactic treatment with a weekly dose of 75 mg of pyrimethamine and 200 mg of dapsone to evaluate sustained effects on renal function. Serum creatinine increased within 28 h from 81 +/- 14 to 102 +/- 16 mumol/liter (P = 0.002) in the healthy volunteers. Blood urea nitrogen, beta 2-microglobulin, and urine remained normal. Creatinine clearance decreased from 125 +/- 27 to 91 +/- 26 ml/min (P < 0.02) without changes in inulin clearance. The effect was reversible within 21 days and attributable to pyrimethamine, as determined by administration of each drug alone. The sustained effect of four doses of pyrimethamine and dapsone in human immunodeficiency virus-infected patients consisted of an analogous rise in serum creatinine from 69 +/- 17 to 87 +/- 32 mumol/liter (P < 0.05). Both creatinine and inulin clearances, however, were unchanged, representing a new equilibrium between creatinine production and elimination at a higher level in serum. Pyrimethamine, thus, may reversibly inhibit renal tubular secretion of creatinine without affecting the glomerular filtration rate. This physiologic effect in pyrimethamine-treated patients must be differentiated from possible organ-related nephropathies.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahmad S. H., Danish T., Faridi M. M., Ahmad A. J., Fakhir S., Khan A. S. Renal function in acute malaria in children. J Trop Pediatr. 1989 Dec;35(6):291–294. doi: 10.1093/tropej/35.6.291. [DOI] [PubMed] [Google Scholar]
- Bauer J. H., Brooks C. S., Burch R. N. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis. 1982 Nov;2(3):337–346. doi: 10.1016/s0272-6386(82)80091-7. [DOI] [PubMed] [Google Scholar]
- Berg K. J., Gjellestad A., Nordby G., Rootwelt K., Djøseland O., Fauchald P., Mehl A., Narverud J., Talseth T. Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients. Nephron. 1989;53(3):218–222. doi: 10.1159/000185747. [DOI] [PubMed] [Google Scholar]
- Berglund F., Killander J., Pompeius R. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol. 1975 Dec;114(6):802–808. doi: 10.1016/s0022-5347(17)67149-0. [DOI] [PubMed] [Google Scholar]
- Bourgoignie J. J., Pardo V. HIV-associated nephropathies. N Engl J Med. 1992 Sep 3;327(10):729–730. doi: 10.1056/NEJM199209033271012. [DOI] [PubMed] [Google Scholar]
- Burgess E., Blair A., Krichman K., Cutler R. E. Inhibition of renal creatinine secretion by cimetidine in humans. Ren Physiol. 1982;5(1):27–30. doi: 10.1159/000172836. [DOI] [PubMed] [Google Scholar]
- Dubb J. W., Stote R. M., Familiar R. G., Lee K., Alexander F. Effect of cimetidine on renal function in normal man. Clin Pharmacol Ther. 1978 Jul;24(1):76–83. doi: 10.1002/cpt197824176. [DOI] [PubMed] [Google Scholar]
- Hoitsma A. J., Wetzels J. F., Koene R. A. Drug-induced nephrotoxicity. Aetiology, clinical features and management. Drug Saf. 1991 Mar-Apr;6(2):131–147. doi: 10.2165/00002018-199106020-00004. [DOI] [PubMed] [Google Scholar]
- Levey A. S., Berg R. L., Gassman J. J., Hall P. M., Walker W. G. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl. 1989 Nov;27:S73–S80. [PubMed] [Google Scholar]
- Levey A. S., Perrone R. D., Madias N. E. Serum creatinine and renal function. Annu Rev Med. 1988;39:465–490. doi: 10.1146/annurev.me.39.020188.002341. [DOI] [PubMed] [Google Scholar]
- Luke D. R., Halstenson C. E., Opsahl J. A., Matzke G. R. Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther. 1990 Nov;48(5):503–508. doi: 10.1038/clpt.1990.186. [DOI] [PubMed] [Google Scholar]
- Myers B. D., Chui F., Hilberman M., Michaels A. S. Transtubular leakage of glomerular filtrate in human acute renal failure. Am J Physiol. 1979 Oct;237(4):F319–F325. doi: 10.1152/ajprenal.1979.237.4.F319. [DOI] [PubMed] [Google Scholar]
- Myers B. D., Okarma T. B., Friedman S., Bridges C., Ross J., Asseff S., Deen W. M. Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest. 1982 Oct;70(4):732–746. doi: 10.1172/JCI110669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Odlind B., Hällgren R., Sohtell M., Lindström B. Is 125I iothalamate an ideal marker for glomerular filtration? Kidney Int. 1985 Jan;27(1):9–16. doi: 10.1038/ki.1985.3. [DOI] [PubMed] [Google Scholar]
- Paller M. S. Drug-induced nephropathies. Med Clin North Am. 1990 Jul;74(4):909–917. doi: 10.1016/s0025-7125(16)30525-9. [DOI] [PubMed] [Google Scholar]
- Seney F. D., Jr, Burns D. K., Silva F. G. Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis. 1990 Jul;16(1):1–13. doi: 10.1016/s0272-6386(12)80779-7. [DOI] [PubMed] [Google Scholar]
- Shannon J. A. THE RENAL EXCRETION OF CREATININE IN MAN. J Clin Invest. 1935 Jul;14(4):403–410. doi: 10.1172/JCI100691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shemesh O., Golbetz H., Kriss J. P., Myers B. D. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985 Nov;28(5):830–838. doi: 10.1038/ki.1985.205. [DOI] [PubMed] [Google Scholar]
- Weber M. W., Böker K., Horstmann R. D., Ehrich J. H. Renal failure is a common complication in non-immune Europeans with Plasmodium falciparum malaria. Trop Med Parasitol. 1991 Jun;42(2):115–118. [PubMed] [Google Scholar]
- van Acker B. A., Koomen G. C., Koopman M. G., de Waart D. R., Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet. 1992 Nov 28;340(8831):1326–1329. doi: 10.1016/0140-6736(92)92502-7. [DOI] [PubMed] [Google Scholar]
- van der Ven A. J., Koopmans P. P., Vree T. B., van der Meer J. W. Adverse reactions to co-trimoxazole in HIV infection. Lancet. 1991 Aug 17;338(8764):431–433. doi: 10.1016/0140-6736(91)91046-w. [DOI] [PubMed] [Google Scholar]